Global GMP Biologics Market Size, Status and Forecast 2019-2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global GMP Biologics Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Monoclonal Antibodies
- 1.4.3 Polyclonal Antibody
- 1.5 Market by Application
- 1.5.1 Global GMP Biologics Market Share by Application (2014-2025)
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 GMP Biologics Market Size
- 2.2 GMP Biologics Growth Trends by Regions
- 2.2.1 GMP Biologics Market Size by Regions (2014-2025)
- 2.2.2 GMP Biologics Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 GMP Biologics Market Size by Manufacturers
- 3.1.1 Global GMP Biologics Revenue by Manufacturers (2014-2019)
- 3.1.2 Global GMP Biologics Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global GMP Biologics Market Concentration Ratio (CR5 and HHI)
- 3.2 GMP Biologics Key Players Head office and Area Served
- 3.3 Key Players GMP Biologics Product/Solution/Service
- 3.4 Date of Enter into GMP Biologics Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global GMP Biologics Market Size by Type (2014-2019)
- 4.2 Global GMP Biologics Market Size by Application (2014-2019)
5 United States
- 5.1 United States GMP Biologics Market Size (2014-2019)
- 5.2 GMP Biologics Key Players in United States
- 5.3 United States GMP Biologics Market Size by Type
- 5.4 United States GMP Biologics Market Size by Application
6 Europe
- 6.1 Europe GMP Biologics Market Size (2014-2019)
- 6.2 GMP Biologics Key Players in Europe
- 6.3 Europe GMP Biologics Market Size by Type
- 6.4 Europe GMP Biologics Market Size by Application
7 China
- 7.1 China GMP Biologics Market Size (2014-2019)
- 7.2 GMP Biologics Key Players in China
- 7.3 China GMP Biologics Market Size by Type
- 7.4 China GMP Biologics Market Size by Application
8 Japan
- 8.1 Japan GMP Biologics Market Size (2014-2019)
- 8.2 GMP Biologics Key Players in Japan
- 8.3 Japan GMP Biologics Market Size by Type
- 8.4 Japan GMP Biologics Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia GMP Biologics Market Size (2014-2019)
- 9.2 GMP Biologics Key Players in Southeast Asia
- 9.3 Southeast Asia GMP Biologics Market Size by Type
- 9.4 Southeast Asia GMP Biologics Market Size by Application
10 India
- 10.1 India GMP Biologics Market Size (2014-2019)
- 10.2 GMP Biologics Key Players in India
- 10.3 India GMP Biologics Market Size by Type
- 10.4 India GMP Biologics Market Size by Application
11 Central & South America
- 11.1 Central & South America GMP Biologics Market Size (2014-2019)
- 11.2 GMP Biologics Key Players in Central & South America
- 11.3 Central & South America GMP Biologics Market Size by Type
- 11.4 Central & South America GMP Biologics Market Size by Application
12 International Players Profiles
- 12.1 Creative Diagnostics
- 12.1.1 Creative Diagnostics Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 GMP Biologics Introduction
- 12.1.4 Creative Diagnostics Revenue in GMP Biologics Business (2014-2019)
- 12.1.5 Creative Diagnostics Recent Development
- 12.2 Fisher Bioservices(Thermo Fisher Scientific)
- 12.2.1 Fisher Bioservices(Thermo Fisher Scientific) Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 GMP Biologics Introduction
- 12.2.4 Fisher Bioservices(Thermo Fisher Scientific) Revenue in GMP Biologics Business (2014-2019)
- 12.2.5 Fisher Bioservices(Thermo Fisher Scientific) Recent Development
- 12.3 Polpharma Biologics
- 12.3.1 Polpharma Biologics Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 GMP Biologics Introduction
- 12.3.4 Polpharma Biologics Revenue in GMP Biologics Business (2014-2019)
- 12.3.5 Polpharma Biologics Recent Development
- 12.4 Intertek
- 12.4.1 Intertek Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 GMP Biologics Introduction
- 12.4.4 Intertek Revenue in GMP Biologics Business (2014-2019)
- 12.4.5 Intertek Recent Development
- 12.5 HemaCare
- 12.5.1 HemaCare Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 GMP Biologics Introduction
- 12.5.4 HemaCare Revenue in GMP Biologics Business (2014-2019)
- 12.5.5 HemaCare Recent Development
- 12.6 AGC
- 12.6.1 AGC Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 GMP Biologics Introduction
- 12.6.4 AGC Revenue in GMP Biologics Business (2014-2019)
- 12.6.5 AGC Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
In 2018, the global GMP Biologics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global GMP Biologics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the GMP Biologics development in United States, Europe and China.
The key players covered in this study
Creative Diagnostics
Fisher Bioservices(Thermo Fisher Scientific)
Polpharma Biologics
Intertek
HemaCare
AGC
...
Market segment by Type, the product can be split into
Monoclonal Antibodies
Polyclonal Antibody
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global GMP Biologics status, future forecast, growth opportunity, key market and key players.
To present the GMP Biologics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of GMP Biologics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.